68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

Chronic Ischemic Heart Disease

Interventions

DRUG

68Ga-NODAGA-E[c(RGDyK)]2

200 MBq 68Ga-NODAGA-E\[c(RGDyK)\]2 administered IV.

Trial Locations (1)

Department of Physiology, Nuclear Medicine and PET, Copenhagen

All Listed Sponsors

lead

Rigshospitalet, Denmark

OTHER